China · Delayed Price · Currency is CNY InventisBio Statistics
Total Valuation
InventisBio has a market cap or net worth of CNY 11.36 billion. The enterprise value is 10.05 billion.
| Market Cap | 11.36B |
| Enterprise Value | 10.05B |
Important Dates
The last earnings date was Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InventisBio has 579.59 million shares outstanding. The number of shares has increased by 1.86% in one year.
| Current Share Class | 579.59M |
| Shares Outstanding | 579.59M |
| Shares Change (YoY) | +1.86% |
| Shares Change (QoQ) | +5.98% |
| Owned by Insiders (%) | 10.01% |
| Owned by Institutions (%) | 42.65% |
| Float | 398.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 159.00 |
| PB Ratio | 8.05 |
| P/TBV Ratio | 8.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 140.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.29, with a Debt / Equity ratio of 0.01.
| Current Ratio | 15.29 |
| Quick Ratio | 14.85 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | -411.12 |
Financial Efficiency
Return on equity (ROE) is -21.38% and return on invested capital (ROIC) is -14.74%.
| Return on Equity (ROE) | -21.38% |
| Return on Assets (ROA) | -14.01% |
| Return on Invested Capital (ROIC) | -14.74% |
| Return on Capital Employed (ROCE) | -26.20% |
| Weighted Average Cost of Capital (WACC) | 5.63% |
| Revenue Per Employee | 374,057 |
| Profits Per Employee | -1.75M |
| Employee Count | 182 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, InventisBio has paid 38,939 in taxes.
| Income Tax | 38,939 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.96% in the last 52 weeks. The beta is 0.25, so InventisBio's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -52.96% |
| 50-Day Moving Average | 21.48 |
| 200-Day Moving Average | 22.80 |
| Relative Strength Index (RSI) | 45.15 |
| Average Volume (20 Days) | 15,827,202 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InventisBio had revenue of CNY 71.44 million and -334.51 million in losses. Loss per share was -0.58.
| Revenue | 71.44M |
| Gross Profit | 65.95M |
| Operating Income | -373.75M |
| Pretax Income | -334.48M |
| Net Income | -334.51M |
| EBITDA | -369.17M |
| EBIT | -373.75M |
| Loss Per Share | -0.58 |
Balance Sheet
The company has 1.33 billion in cash and 18.80 million in debt, with a net cash position of 1.31 billion or 2.26 per share.
| Cash & Cash Equivalents | 1.33B |
| Total Debt | 18.80M |
| Net Cash | 1.31B |
| Net Cash Per Share | 2.26 |
| Equity (Book Value) | 1.41B |
| Book Value Per Share | 2.43 |
| Working Capital | 1.37B |
Cash Flow
In the last 12 months, operating cash flow was -236.14 million and capital expenditures -7.30 million, giving a free cash flow of -243.44 million.
| Operating Cash Flow | -236.14M |
| Capital Expenditures | -7.30M |
| Depreciation & Amortization | 4.58M |
| Net Borrowing | -1.28M |
| Free Cash Flow | -243.44M |
| FCF Per Share | -0.42 |
Margins
| Gross Margin | 92.31% |
| Operating Margin | -523.13% |
| Pretax Margin | -468.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InventisBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.86% |
| Shareholder Yield | -1.86% |
| Earnings Yield | -2.94% |
| FCF Yield | -2.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
InventisBio has an Altman Z-Score of 84.8 and a Piotroski F-Score of 1.
| Altman Z-Score | 84.8 |
| Piotroski F-Score | 1 |